Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8
RESEARCH TOOLSreports
BioMarin Pharmaceutical (BM8) Ownership Overview
0.95% Insiders
37.18%
Mutual Funds
30.70% Other Institutional Investors
22.65% ETFs
8.52% Public Companies and
Individual Investors
The ownership structure of BioMarin Pharmaceutical (DE:BM8) stock is a mix of institutional, retail, and individual investors. Approximately 90.53% of the company’s stock is owned by Institutional Investors, 0.95% is owned by Insiders, and 8.52% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 07, 2025 | Charles Greg Guyer Evp, Cto | xxxxxxxxxxxxx | $501313 |
| Nov 14, 2024 | Charles Greg Guyer Evp, Cto | xxxxxxxxxxxxx | $350301 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $1380 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $659929 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $771275 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $917985 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,413,164 | Institution | 9.65% | 1,308,641,979 | |
| 18,189,171 | Institution | 9.53% | 1,292,722,572 | |
| 16,873,529 | Institution | 8.84% | 1,199,218,580 | |
| 14,746,235 | Institution | 7.73% | 1,048,029,668 | |
| 13,621,372 | Institution | 7.14% | 968,084,529 | |
| 11,525,325 | Institution | 6.04% | 819,116,373 | |
| 10,510,550 | Institution | 5.51% | 746,995,299 | |
| 7,165,088 | Institution | 3.76% | 509,229,969 | |
| 6,405,939 | Institution | 3.36% | 455,276,491 | |
| 5,887,732 | Institution | 3.09% | 418,447,001 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,873,529 | Institution | 8.84% | 1,199,218,580 | |
| 11,525,325 | Institution | 6.04% | 819,116,373 | |
| 7,165,088 | Institution | 3.76% | 509,229,969 | |
| 6,405,939 | Institution | 3.36% | 455,276,491 | |
| 5,887,732 | Institution | 3.09% | 418,447,001 | |
| 4,494,821 | Institution | 2.36% | 319,451,423 | |
| 3,355,166 | Institution | 1.76% | 238,455,003 | |
| 2,022,822 | Institution | 1.06% | 143,763,982 | |
| 1,895,769 | Institution | 0.99% | 134,734,199 | |
| 808,714 | Institution | 0.42% | 57,476,113 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns BioMarin Pharmaceutical (DE:BM8)?
According to the latest TipRanks data, approximately 30.70% of the company's stock is held by institutional investors, 0.95% is held by insiders, and 8.52% is held by retail investors.
What percentage of BioMarin Pharmaceutical (DE:BM8) stock is held by institutional investors?
According to the latest TipRanks data, approximately 30.70% of BioMarin Pharmaceutical (DE:BM8) stock is held by institutional investors.
What percentage of BioMarin Pharmaceutical (DE:BM8) stock is held by retail investors?
According to the latest TipRanks data, approximately 8.52% of BioMarin Pharmaceutical (DE:BM8) stock is held by retail investors.
Who owns the most shares of BioMarin Pharmaceutical (DE:BM8)?
Vanguard owns the most shares of BioMarin Pharmaceutical (DE:BM8).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.